A Phase I Dose Escalation Study of Darinaparsin in Combination With CHOP in Previously Untreated Patients With Lymphomas Who Are Scheduled to Receive CHOP Alone.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Darinaparsin (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications B cell lymphoma; Hodgkin's disease; Non-Hodgkin's lymphoma; T cell lymphoma
- Focus Adverse reactions
- 26 May 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 13 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Jun 2010 New trial record